Annotation Detail for CLDN23

Basic Information
Top
Pathway ID | Pathway Name |
---|
| Cell junction organization |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of CLDN23 mRNA | affects expression | 21346803
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of CLDN23 mRNA | increases expression | 20106945
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CLDN23 mRNA | affects binding|increases activity|increases expression | 19710929
|
D011374 |
Progesterone |
NCOA2 protein affects the reaction [Progesterone results in increased expression of CLDN23 mRNA] | affects reaction|increases expression | 17556502
|
D011374 |
Progesterone |
Progesterone results in increased expression of CLDN23 mRNA | increases expression | 17556502
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.58 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.06 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.86 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.11 | 16434500 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.64 | 19183758 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.57 | 19483382 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
6.06 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.82 | 15845082 15380490 15665606 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.13 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.13 | 15562024 16175315 17614352 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
1.79 | 16705839 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.13 | 20419170 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.12 | 19176532 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.58 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.57 | 18249437 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
5.05 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
2.05 | 21346803 18551238 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.90 | 12083418 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
4.28 | 17692515 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
4.16 | 16134523 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.08 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.19 | 20131406 19236843 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.83 | 20471113 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.76 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.55 | 19772884 18467677 19176532 16221962 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.58 | 20558911 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.96 | 15869954 |
MESH:D007249 |
Inflammation |
|
Progesterone |
2.77 | 15869954 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.87 | 16306350 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
3.32 | 16705839 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.77 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.77 | 20007298 15890375 16377806 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
1.57 | 18569708 20464547 18816296 18520028 20135361 17053015 20064080 6695378 20869020 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
3.10 | 11408345 17203775 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.50 | 16381670 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
4.07 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.27 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.25 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.49 | 18551238 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.39 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.39 | 17405874 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.88 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.82 | 12819281 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
2.62 | 16525653 17393432 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.91 | 17292933 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.55 | 19058328 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.96 | 18045962 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.79 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.52 | 19755658 10029692 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.91 | 15862959 16503802 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.39 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.39 | 17053015 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.95 | 10091137 |